New England Asset Management Inc Gsk PLC Transaction History

New England Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $239,765 - $270,782	-6,343 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $251,246 - $271,226	6,343 New	6,343 $256,000
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $701,463 - $831,673	-19,849 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $782,844 - $824,725	19,849	19,849 $806,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on New England Asset Management Inc with notifications on news.